General pharmacology studies in the pharmaceutical industry: Example of a basic program

Drug Development Research

Volumn 42, Issue 2, 1997, Pages 57-62

  Pairet, Michel ^a   Diederen, Willi ^a   Guth, Brian ^a   Kanai, Kozo ^b   Mauz, Annerose ^a   Pieper, Michael ^a   Van Ryn, Joanne ^a   Schierok, Hans ^a   Walland, Alexander ^a   Winquist, Ray ^c  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^b NIPPON BOEHRINGER INGELHEIM CO LTD   (Japan)

^c BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

General pharmacology; Good laboratory practice; Methods; Regulatory authorities

Indexed keywords

ARTICLE; DRUG DEVELOPMENT; DRUG INDUSTRY; DRUG RESEARCH; GOOD LABORATORY PRACTICE; GOOD MANUFACTURING PRACTICE; HUMAN; METHODOLOGY; NONHUMAN; PHARMACOLOGY; PRACTICE GUIDELINE; TECHNIQUE;

EID: 0031447812     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199710)42:2<57::AID-DDR1>3.0.CO;2-O     Document Type: Article

References (13)

1. Anon. (1987): United States of America Guidelines for the Format and Content of the Non-Clinical Pharmacology/Toxicology Section of an Application, 21 CFR sections 312.33 (IND) and 314.50 (NDA). Washington, DC: Food and Drug Administration.
2. Anon. (1991a): Drug Registration Requirements in Japan, 4th Ed. Tokyo: Yakuji Nippon Ltd.
3. Anon. (1991b): European Community Directive 91/507/EEC.
4. Anon. (1992a): The OECD Principles of Good Laboratory Practice. Organisation for Economic Cooperation and Development. Monograph No. 45, OECD, Paris, France.
5. Anon. (1992b): Applicability of Good Laboratory Practices. Committee for Proprietary Medicinal Products. III/3824/92 Rev. 1.
6. Anon. (1995a): Guidelines for Non-Clinical Safety Studies for the Conduct of Human Clinical Trials for Pharmaceuticals. International Conference on Harmonization (ICH) of Technical Requirements for the Registration of Pharmaceuticals for Human Use Draft #6, 12/ 30/95, Geneva, Switzerland: ICH Secretariat Office.
7. Anon. (1995b): Japanese Guidelines for General Pharmacology Studies, Japanese Guidelines for Nonclinical Studies of Drugs Manual. Tokyo: Yakuji Nippo Ltd., pp 69-126.
8. Anon. (1995c): French Working Group on Safety Pharmacology (1995): Safety Pharmacology Studies in Medicinal Product Development. Draft version. Coordinator, R. Boulu, Faculté de Pharmacie, Paris, France.
9. Anon. (1997): Japanese Ministry of Health and Welfare: Revised Pharmaceutical Affairs Law 1997 (in Japanese).
10. Irwin S (1968): Comprehensive observation assessment: Ia. A systematic, quantitative procedure for assessing the behavioural and physiologic state of the mouse. Psychopharmacologia 13:222-257.
11. Kinter LB (1995): General pharmacology / safety pharmacology: Customers, biologies and GLPs. Drug Dev Res 35:142-144.
12. Kinter LB, Dixon LW (1995): Safety pharmacology program for pharmaceuticals. Drug Dev Res 35:179-182.
13. Mizuguchi K, Kanai K, Igarashi T (1996): Update of general pharmacology / safety pharmacology studies in Japan. Drug Dev Res 38:114-115.